The threat of antimalarial drug resistance

The battle between man and malaria has continued for thousands of years. Antimalarial drugs are essential weapons to fight the disease, but their efficacy is threatened by drug resistance which continues to emerge creating a major obstacle to malaria control and jeopardizing renewed hopes for elimin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanboonkunupakarn, Borimas, White, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530994/
https://www.ncbi.nlm.nih.gov/pubmed/28883954
http://dx.doi.org/10.1186/s40794-016-0027-8
_version_ 1783253330623987712
author Hanboonkunupakarn, Borimas
White, Nicholas J.
author_facet Hanboonkunupakarn, Borimas
White, Nicholas J.
author_sort Hanboonkunupakarn, Borimas
collection PubMed
description The battle between man and malaria has continued for thousands of years. Antimalarial drugs are essential weapons to fight the disease, but their efficacy is threatened by drug resistance which continues to emerge creating a major obstacle to malaria control and jeopardizing renewed hopes for elimination. As 2016 is the first year under WHO Global Technical Strategy for Malaria 2016–2030, it is a good time to ponder the progress of both sides and plan for the future.
format Online
Article
Text
id pubmed-5530994
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55309942017-09-07 The threat of antimalarial drug resistance Hanboonkunupakarn, Borimas White, Nicholas J. Trop Dis Travel Med Vaccines Review The battle between man and malaria has continued for thousands of years. Antimalarial drugs are essential weapons to fight the disease, but their efficacy is threatened by drug resistance which continues to emerge creating a major obstacle to malaria control and jeopardizing renewed hopes for elimination. As 2016 is the first year under WHO Global Technical Strategy for Malaria 2016–2030, it is a good time to ponder the progress of both sides and plan for the future. BioMed Central 2016-07-07 /pmc/articles/PMC5530994/ /pubmed/28883954 http://dx.doi.org/10.1186/s40794-016-0027-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Hanboonkunupakarn, Borimas
White, Nicholas J.
The threat of antimalarial drug resistance
title The threat of antimalarial drug resistance
title_full The threat of antimalarial drug resistance
title_fullStr The threat of antimalarial drug resistance
title_full_unstemmed The threat of antimalarial drug resistance
title_short The threat of antimalarial drug resistance
title_sort threat of antimalarial drug resistance
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530994/
https://www.ncbi.nlm.nih.gov/pubmed/28883954
http://dx.doi.org/10.1186/s40794-016-0027-8
work_keys_str_mv AT hanboonkunupakarnborimas thethreatofantimalarialdrugresistance
AT whitenicholasj thethreatofantimalarialdrugresistance
AT hanboonkunupakarnborimas threatofantimalarialdrugresistance
AT whitenicholasj threatofantimalarialdrugresistance

Ejemplares similares